<DOC>
	<DOCNO>NCT00806858</DOCNO>
	<brief_summary>This study conduct Asia . The aim observational study evaluate subject ' treatment satisfaction evaluate subject ' preference pen device incidence clinical technical complains use NovoPen® 4 normal clinical practice condition .</brief_summary>
	<brief_title>Observational Study NovoPen® 4 Treatment Satisfaction Insulin Therapy Type 1 Type 2 Subjects With Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Any subject Type 1 Type 2 diabetes accept use NovoPen® 4 . The selection discretion individual physician . A study specific sign informed consent must sign subject studyrelated activity information collect , require local regulation Subjects unlikely comply protocol , e.g. , unwillingness cooperate , inability return final visit Subjects know suspect allergy insulin excipients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>